Cjc-1295 is also referred to as Mod GRF 1-29, which in most cases is recommended to exceed CJC-1295. The duration of the effect of the product is different. MOD GRF shortens the desired duration of the drug, and CJC-1295 has the effect of preventing the prolongation of the duration of such effects. 2.CJC-1295, also known as DAC: GRF (short for drug affinity complex) is a synthetic analogue of hormone releasing hormone (GHRH) (also known as growth hormone releasing factor (GRF)) and hormone GHS), which was developed by ConjuChem Biotechnologies. It is an improvement with improved pharmacokinetics, particularly with regard to half-life of GHRH (1-29). CJC-1295 has been shown to prolong the half-life and bioavailability of somatotropin-releasing hormone 1-29. It increases the half-life of the agent by bioconjugation.
What’s the usage?
1.enhances protein production in the body
2.boosts muscle mass
3.induces lipolysis – the breakdown of fat tissue
4.boosts recovery from injuries
5.increases bone density
6.reduces aging factors like skin wrinkles
7.stimulate cell growth
8.treat withered tissue or organs